novo nordisk new glp 1 asks FDA to prevent compounders from making GLP-1 knockoffs Novo Nordisk's weight loss pill

Dysbiosis leads to impaired lipid metabolism, resulting in dyslipidemia, a common complication among patients with kidney disease that precipitates atherosclerosis and cardiovascular disorders [93]

& le Roux, C

We modeled an optimistic scenario using the best possible weight loss outcomes and long-term risk reductions, said first author Jennifer Hwang, DO, a primary care physician at UChicago Medicine

2016 Mar;38(3):187-95

Isoproterenol hydrochloride, which has physiological effects similar to those of the stimulating hormone epinephrine, is a powerful cardiac drug that could seriously harm or prove fatal if given by accident to a patient with an underlying heart condition

[101] Hamilton-Reeves JM, Banerjee S, Banerjee SK, et al